Wird geladen...
Ranolazine for stable angina pectoris
BACKGROUND: Stable angina pectoris is a chronic medical condition with significant impact on mortality and quality of life; it can be macrovascular or microvascular in origin. Ranolazine is a second‐line anti‐anginal drug approved for use in people with stable angina. However, the effects of ranolaz...
Gespeichert in:
| Veröffentlicht in: | Cochrane Database Syst Rev |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Ltd
2017
|
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6373632/ https://ncbi.nlm.nih.gov/pubmed/28178363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011747.pub2 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|